GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Other Gross PPE

GH Research (FRA:1KA) Other Gross PPE : €0.90 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is GH Research Other Gross PPE?

GH Research's Other Gross PPE for the quarter that ended in Mar. 2024 was €0.90 Mil.

GH Research's quarterly Other Gross PPE increased from Sep. 2023 (€1.01 Mil) to Dec. 2023 (€1.10 Mil) but then declined from Dec. 2023 (€1.10 Mil) to Mar. 2024 (€0.90 Mil).

GH Research's annual Other Gross PPE declined from Dec. 2021 (€0.03 Mil) to Dec. 2022 (€0.01 Mil) but then increased from Dec. 2022 (€0.01 Mil) to Dec. 2023 (€1.10 Mil).


GH Research Other Gross PPE Historical Data

The historical data trend for GH Research's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Other Gross PPE Chart

GH Research Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
- - 0.03 0.01 1.10

GH Research Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.14 1.09 1.01 1.10 0.90

GH Research Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


GH Research (FRA:1KA) Business Description

Traded in Other Exchanges
Address
28 Baggot Street Lower, Dublin, IRL, D02 NX43
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

GH Research (FRA:1KA) Headlines

No Headlines